Highlights of the 2nd Annual Rational Combinations 360° Conference August 11, 2017December 14, 2022 Arthur N. Brodsky, PhD
Nivolumab Approved for Patients with Chemotherapy-Resistant, Metastatic, MSI-H Colorectal Cancer August 1, 2017December 14, 2022 Arthur N. Brodsky, PhD
Recapping Our 5th Annual Cancer Immunotherapy Month July 31, 2017December 14, 2022 Arthur N. Brodsky, PhD
Rational Combinations 360° Seeks Improved Immunotherapy Approaches for Patients June 27, 2017December 14, 2022 Arthur N. Brodsky, PhD
CRI's CEO, Scientific Advisors Headline Cancer Immunotherapy Forum June 23, 2017December 14, 2022 Arthur N. Brodsky, PhD
ASCO17 Recap: 7 Takeaways from the World’s Premier Clinical Cancer Conference June 16, 2017December 14, 2022 Arthur N. Brodsky, PhD